Cargando…

Perioperative diagnostics of patients referred for radioiodine therapy of differentiated thyroid carcinoma: referral center experience in an iodine-insufficient country

PURPOSE: The interdisciplinary “Martinique-Principles” of four international professional societies concerned with the patient management of differentiated thyroid cancer (DTC) patients were agreed upon. Differences in perioperative diagnostics can lead to differences in clinical decision founding r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Eilsberger, Friederike, Tuttle, R. Michael, Librizzi, Damiano, Pfestroff, Andreas, Luster, Markus, Verburg, Frederik A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8159782/ https://www.ncbi.nlm.nih.gov/pubmed/33135124 http://dx.doi.org/10.1007/s12020-020-02509-9

Ejemplares similares

Real-Life Performance of F-18-FDG PET/CT in Patients with Cervical Lymph Node Metastasis of Unknown Primary Tumor
por: Eilsberger, Friederike, et al.
Publicado: (2022)

Prostate-Specific Membrane Antigen in Anaplastic and Poorly Differentiated Thyroid Cancer—A New Diagnostic and Therapeutic Target?
por: Wächter, Sabine, et al.
Publicado: (2021)

Application of the American Thyroid Association Risk Assessment in Patients with Differentiated Thyroid Carcinoma in a German Population
por: Eilsberger, Friederike, et al.
Publicado: (2023)

Diagnostic Impact of Dual-Time PET/CT with (68)Gallium-PSMA in Prostate Cancer and (68)Gallium-DOTATOC in Neuroendocrine Tumors
por: Librizzi, Damiano, et al.
Publicado: (2023)

Adjuvant Radioiodine for Intermediate-Risk Papillary Thyroid Cancer—To Treat or Not to Treat
por: van Velsen, Evert F S, et al.
Publicado: (2023)

The EANM guideline on radioiodine therapy of benign thyroid disease
por: Campennì, Alfredo, et al.
Publicado: (2023)

Dietary Iodine Intake, Therapy with Radioiodine, and Anaplastic Thyroid Carcinoma
por: Besic, Nikola, et al.
Publicado: (2020)

Second primary malignancies induced by radioactive iodine treatment of differentiated thyroid carcinoma — a critical review and evaluation of the existing evidence
por: Reinecke, Maximilian J., et al.
Publicado: (2022)

Radioiodine treatment of differentiated thyroid cancer despite history of ‘iodine allergy’
por: Puchalski, Adam R, et al.
Publicado: (2014)

Redifferentiating Thyroid Cancer: Selumetinib-enhanced Radioiodine Uptake in Thyroid Cancer
por: Larson, Steven M., et al.
Publicado: (2017)

Questions and Controversies in the Clinical Application of Tyrosine Kinase Inhibitors to Treat Patients with Radioiodine-Refractory Differentiated Thyroid Carcinoma: Expert Perspectives
por: Verburg, Frederik A., et al.
Publicado: (2021)

Pediatric papillary thyroid cancer: current management challenges
por: Verburg, Frederik A, et al.
Publicado: (2016)

A comparison of thyroidal protection by iodine and perchlorate against radioiodine exposure in Caucasians and Japanese
por: Rump, A., et al.
Publicado: (2021)

Normal organ dosimetry for thyroid cancer patients treated with radioiodine as part of the multi-centre multi-national Horizon 2020 MEDIRAD project
por: Taprogge, Jan, et al.
Publicado: (2023)

A comparison of thyroidal protection by stable iodine or perchlorate in the case of acute or prolonged radioiodine exposure
por: Eder, Stefan, et al.
Publicado: (2020)

New! F-18-based PET/CT for sodium-iodine-symporter-targeted imaging!
por: Verburg, Frederik A., et al.
Publicado: (2020)

Effect of a Low Iodine Diet vs. Restricted Iodine Diet on Postsurgical Preparation for Radioiodine Ablation Therapy in Thyroid Carcinoma Patients
por: Lim, Chi Young, et al.
Publicado: (2015)

Misdiagnosis of Paraganglioma by (123)I-mIBG Without Stable Iodine Blockade of Thyroidal Radioiodine Uptake
por: Chen Cardenas, Stanley M, et al.
Publicado: (2020)

Thyroid-Stimulating Hormone Reference Ranges in the First Trimester of Pregnancy in an Iodine-Sufficient Country
por: Castillo, Carmen, et al.
Publicado: (2018)

Lenvatinib for the Treatment of Radioiodine-Refractory Differentiated Thyroid Cancer: Treatment Optimization for Maximum Clinical Benefit
por: Wirth, Lori J, et al.
Publicado: (2022)

2022 ETA Consensus Statement: What are the indications for post-surgical radioiodine therapy in differentiated thyroid cancer?
por: Pacini, Furio, et al.
Publicado: (2021)

False-positive radioiodine uptake after radioiodine treatment in differentiated thyroid cancer
por: Barbaro, Daniele, et al.
Publicado: (2023)

Radioiodine in Differentiated Thyroid Carcinoma: Do We Need Diagnostic Pre-Ablation Iodine-123 Scintigraphy to Optimize Treatment?
por: de Koster, Elizabeth J., et al.
Publicado: (2021)

Genetic alterations of differentiated thyroid carcinoma in iodine‐rich and iodine‐deficient countries
por: Vuong, Huy Gia, et al.
Publicado: (2016)

Differentiated thyroid cancer patients potentially benefitting from postoperative I-131 therapy: a review of the literature of the past decade
por: Verburg, Frederik A., et al.
Publicado: (2019)

Utility of Iodine-131 hybrid SPECT-CT fusion imaging before high-dose radioiodine therapy in papillary thyroid carcinoma
por: Bhattacharya, Anish, et al.
Publicado: (2010)

Results of the SEL-I-METRY Phase II Trial on Resensitization of Advanced Iodine Refractory Differentiated Thyroid Cancer to Radioiodine Therapy
por: Wadsley, Jon, et al.
Publicado: (2023)

Use of lenvatinib in the treatment of radioiodine-refractory differentiated thyroid cancer: a multidisciplinary perspective for daily practice
por: Capdevila, Jaume, et al.
Publicado: (2023)

Individualized multimodal treatment strategy for anaplastic thyroid carcinoma—Case report of long-term remission and review of literature
por: Eckhardt, S., et al.
Publicado: (2016)

Effect of TSH stimulation protocols on adequacy of low-iodine diet for radioiodine administration
por: Lee, Hwanhee, et al.
Publicado: (2021)

Use of multikinase inhibitors/lenvatinib concomitant with radioiodine for the treatment of radioiodine refractory differentiated thyroid cancer
por: Herranz, Urbano Anido
Publicado: (2022)

Mutation-based, short-term “neoadjuvant” treatment allows resectability in stage IVB and C anaplastic thyroid cancer
por: Maurer, Elisabeth, et al.
Publicado: (2023)

Theophylline Increases the Uptake of Radioiodine by Mouse Thyroid
por: Lee, Jong Min, et al.
Publicado: (2004)

Radioiodine for thyroid cancer: sometimes, less is best
por: Padovani, Rosalia do Prado
Publicado: (2016)

Incidence of microcytosis in hyperthyroid cats referred for radioiodine treatment
por: Gil-Morales, Claudia, et al.
Publicado: (2021)

Epigenetic Modifications in Thyroid Cancer Cells Restore NIS and Radio-Iodine Uptake and Promote Cell Death
por: Wächter, Sabine, et al.
Publicado: (2018)

The World Association of Radiopharmaceutical and Molecular Therapy position statement on the initial radioiodine therapy for differentiated thyroid carcinoma
por: Dizdarevic, S, et al.
Publicado: (2019)

Radioiodine refractoriness score: A multivariable prediction model for postoperative radioiodine‐refractory differentiated thyroid carcinomas
por: Li, Genpeng, et al.
Publicado: (2018)

Synthesis and characterization of iodovanadinite using PdI(2,) an iodine source for the immobilisation of radioiodine
por: Johnstone, E. V., et al.
Publicado: (2020)

Capsaicin restores sodium iodine symporter-mediated radioiodine uptake through bypassing canonical TSH‒TSHR pathway in anaplastic thyroid carcinoma cells
por: Xu, Shichen, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_29b8o610spt29otfu1bbsuvbfe